Leading the Way in Life Science Technologies

GEN Exclusives

More »


More »

For full access to this article login to GEN Select now.

April 15, 2014 (Vol. 34, No. 8)

Selecting the Right Drug Candidate

Accurately Predicting In Vivo Hepatotoxicity

  • In 2013, the cost of identifying and developing a new drug was on average between $350 million and $5 billion. One major reason for such high development costs is that 95% of the drugs entering clinical trials fail to be both effective and safe. Hepatotoxicity accounts for a ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.